The high costs of pyridine nucleotide cofactors have limited the applications of NAD(P)-dependent oxidoreductases on an industrial scale. Although NAD(P)H regeneration systems have been widely studied, NAD(P)+ regeneration, which is required in reactions where the oxidized form of the cofactor is used, has been less well explored, particularly in whole-cell biocatalytic processes.
Simultaneous overexpression of an NAD+ dependent enzyme and an NAD+ regenerating enzyme (H2O producing NADH oxidase from Lactobacillus brevis) in a whole-cell biocatalyst was studied for application in the NAD+-dependent oxidation system. The whole-cell biocatalyst with (2R,3R)-2,3-butanediol dehydrogenase as the catalyzing enzyme was used to produce (3R)-acetoin, (3S)-acetoin and (2S,3S)-2,3-butanediol.
A recombinant strain, in which an NAD+ regeneration enzyme was coexpressed, displayed significantly higher biocatalytic efficiency in terms of the production of chiral acetoin and (2S,3S)-2,3-butanediol. The application of this coexpression system to the production of other chiral chemicals could be extended by using different NAD(P)-dependent dehydrogenases that require NAD(P)+ for catalysis.
Citation: Xiao Z, Lv C, Gao C, Qin J, Ma C, Liu Z, et al. (2010) A Novel Whole-Cell Biocatalyst with NAD+ Regeneration for Production of Chiral Chemicals. PLoS ONE 5(1): e8860. https://doi.org/10.1371/journal.pone.0008860
Editor: Stefan Wölfl, Universität Heidelberg, Germany
Received: August 14, 2009; Accepted: December 31, 2009; Published: January 26, 2010
Copyright: © 2010 Xiao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was partly supported by the National Natural Science Foundation of China (30770064 and 30821005), Chinese National Programs for High Technology Research and Development (2006AA02Z244) and National Basic Research Program of China (2007CB707803). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Many approaches have been developed to produce chiral chemicals for the manufacture of a wide range of intermediates in the pharmaceutical, agrochemical, fine chemical and food industries . In recent years, biocatalysis has emerged as a powerful strategy for the production of enantiomerically pure building blocks that cannot be obtained through chemical and fermentation processes . NAD(P)-dependent oxidation systems have been used for the kinetic resolution of chiral alcohols and amines from a mixture of stereoisomers and for the production of ketones that are difficult to synthesize chemically –. However, due to the high costs of pyridine cofactors, an efficient cofactor regeneration system is a prerequisite for the commercial viability of a process –.
Whole cells have some NAD+ and NADP+ reserves that provide a continuous source of cofactors . Therefore, whole cells are used in many applications of dehydrogenases. Simultaneous overexpression of target enzymes and NAD(P)H regeneration enzymes in whole-cell biocatalysts has been carried out in many asymmetric reduction systems –. In this study, NAD+ regeneration by whole-cell biocatalysis was used to extend the applications of NAD(P) +-dependent oxidoreductases.
Chiral acetoin (AC) is widely used to synthesize novel optically active α-hydroxyketone derivatives and liquid crystal composites . Chemical syntheses or fermentations generally lead to the production of a mixture of both isomers . Therefore, it is essential to find an effective biocatalytic process to produce enantiomerically pure AC. In the presence of NAD+, NAD-dependent (2R,3R)-2,3-butanediol dehydrogenase (BDH) can theoretically catalyze the stereospecific oxidation of (2R,3R)-2,3-butanediol (BD) and meso-2,3-BD to (3R)-AC and (3S)-AC, as shown in Scheme S1, respectively –.
Similar to other dehydrogenases, BDHs require NAD+ and NADH as cofactors –. During the catalytic process, NAD+ is reduced to NADH, and 2,3-BD is oxidized to AC. Thus, during the course of one cycle, NAD+ is depleted while NADH and AC are accumulated. A cofactor regeneration process is necessary to obtain high AC productivity. In contrast to the more common NADH oxidase (NOX) that converts O2 to H2O2, the unique NOX from Lactobacillus brevis regenerates NAD+ from NADH by reducing O2 to H2O –. Since proteins are deactivated upon exposure to H2O2, the novel characteristics of the NOX from L. brevis make it a promising alternative for NAD+ regeneration. In this study, we developed a coexpression system in which acetoin reductase/2,3-BDH encoded by the Bacillus subtilis ydjL (bdhA) gene was the producing enzyme and NOX was the cofactor-regenerating enzyme. Our intention was to develop a novel biocatalytic process for the efficient production of (3R)-AC and (3S)-AC with high enantiomeric excess (ee).
Results and Discussion
Construction of the Whole-Cell Biocatalyst
First, Escherichia coli BL21(DE3) (pETDuet-ydjL) carrying ydjL, which encodes (2R,3R)-2,3-BDH from B. subtilis 168 was constructed. The crude extract of induced E. coli BL21(DE3) (pETDuet-ydjL) cells showed a high (2R,3R)-2,3-BDH activity of 16.0 U mg−1 (in the direction of (2R,3R)-2,3-BD production). Next, E. coli BL21(DE3) (pETDuet-nox) harboring nox, which encodes NOX from L. brevis, was constructed. The crude extract of induced E. coli BL21(DE3) (pETDuet-nox) cells showed a high NOX activity of 7.2 U mg−1 (SDS-PAGE analyses of the recombinant proteins are shown in Fig. 1). The biocatalytic activities of the crude extracts prepared from E. coli BL21(DE3) (pETDuet-nox) and E. coli BL21(DE3) (pETDuet-ydjL) cells were assayed using meso-2,3-BD and (2R,3R)-2,3-BD as the substrates. However, no notable production of AC was detected.
Lane M, marker proteins; lane 1, E. coli BL21(DE3); lane 2, E. coli BL21(DE3) (pETDuet); lane 3, E. coli BL21(DE3) (pETDuet-ydjL); lane 4, E. coli BL21(DE3) (pETDuet-nox); and lane 5, E. coli BL21(DE3) (pETDuet-ydjLnox).
In comparison with free enzymes, whole-cell biocatalysts are much more convenient to use and less expensive to prepare . Enzymes in whole cells are more stable than isolated enzymes because these are protected from the external environment. The biocatalytic activities of the whole-cell biocatalyst prepared from E. coli BL21(DE3) (pETDuet-ydjL) were determined using meso-2,3-BD, (2R,3R)-2,3-BD, and (2S,3S)-2,3-BD as the substrates. As shown in Table 1, the whole-cell biocatalyst of E. coli BL21(DE3) (pETDuet-ydjL) had almost the same biocatalytic activities on meso-2,3-BD and (2R,3R)-2,3-BD but had no activity on (2S,3S)-2,3-BD.
To obtain high AC productivity, we decided to couple a cofactor regeneration system, in which biocatalysis was performed using whole cells of both E. coli BL21(DE3) (pETDuet-ydjL) and E. coli BL21(DE3) (pETDuet-nox) as catalysts. However, no enhancement of the biocatalytic activity of E. coli BL21(DE3) (pETDuet-ydjL) system was detected with supplemented whole cells of E. coli BL21(DE3) (pETDuet-nox). This may be due to the fact that (2R,3R)-2,3-BDH and NOX are physically separated and expressed in different cells, and the cellular membrane of the cells might retard the exchange of pyridine cofactors between E. coli BL21(DE3) (pETDuet-nox) and E. coli BL21(DE3) (pETDuet-ydjL). To validate this observation, E. coli BL21(DE3) (pETDuet-ydjLnox) cells were constructed in which NOX, the NAD+ regeneration enzyme, was coexpressed with (2R,3R)-2,3-BDH, the catalyzing enzyme, as shown in Fig. 1.
Although the two genes were coexpressed on one expression vector, they were placed under two separate T7 lac promoters so that the expression of one gene would not affect that of the other. NOX could oxidize the NADH produced by (2R,3R)-2,3-BDH and provide the oxidized form of the pyridine nucleotide cofactor for the biocatalytic process, without any hindrance from the transmembrane process. As shown in Table 1, the whole-cell biocatalytic activity of E. coli BL21(DE3) (pETDuet-ydjLnox) on meso-2,3-BD (15.8 U mL−1) was about twice that of E. coli BL21(DE3) (pETDuet-ydjL) (8.1 U mL−1). The results indicated that recombinant E. coli BL21(DE3) (pETDuet-ydjLnox) could increase biocatalytic efficiency of BDH by co-expressing an NAD+ regeneration enzyme. Production of (3S)-AC, (3R)-AC, and (2S,3S)-2,3-BD was possible using E. coli BL21(DE3) (pETDuet-ydjLnox) as the biocatalyst and 2,3-BD as the substrate, as shown in Fig. 2.
Effects of pH and Substrate Concentration on Chiral AC Biosynthesis
To achieve high product concentrations, the effect of pH on the yield of AC from 2,3-BD was investigated. As shown in Fig. 3A, reactions with 43.0 g L−1 of meso-2,3-BD as the substrate and 5.0 g dry cell weight (DCW) L−1 of E. coli BL21(DE3) (pETDuet-ydjLnox) as the biocatalyst were carried out under different conditions. After 6 h of reaction with E. coli BL21(DE3) (pETDuet-ydjLnox), the reaction rates were measured by monitoring the yield of (3S)-AC. The results showed that the reaction rate was the highest at pH 8.0. It was reported that the optimum pH value for the conversion of 2,3-BD to AC by (2R,3R)-2,3-BDH was 9.0 and 5.5∼7.0 for NOX , . When the two enzymes were coexpressed and functioned together, the optimum pH value was 8.0.
A. pH; B. substrate concentration. E. coli BL21(DE3) (pETDuet-ydjLnox) was incubated with meso-2,3-BD in the reaction.
Substrate concentration is another important parameter in the catalytic process, and it requires careful investigation because high substrate concentrations may lead to substrate inhibition. The effect of the substrate concentration on the conversion rate was tested (Fig. 3B). The results showed that in the range 8∼61 g L−1, the conversion rate of meso-2,3-BD decreased sharply from 100% to 47.5% as the concentration increased. Simultaneously, the concentration of (3S)-AC increased linearly with the increase in the substrate concentration from 8 g L−1 to 43 g L−1, but when the substrate concentration increased beyond 43 g L−1, the concentration of (3S)-AC decreased rapidly. It is known that AC can be easily separated from the reaction solution due to its low boiling point and that residual 2,3-BD can be reused. Therefore, 43 g L−1 of meso-2,3-BD was selected as a suitable substrate concentration based on the final yield of (3S)-AC.
Production of Chiral AC by Recombinant E. coli
To evaluate the efficiency of whole-cell in the biosynthesis of chiral AC, recombinants E. coli BL21(DE3) (pETDuet-ydjLnox) and E. coli BL21(DE3) (pETDuet-ydjL) were used to catalyze the conversion of meso-2,3-BD to (3S)-AC (E. coli BL21(DE3) was used as the control). As shown in Fig. 4, under optimal reaction conditions, the final concentration of (3S)-AC produced by recombinant E. coli BL21(DE3) (pETDuet-ydjLnox) was 36.7 g L−1 from 43 g L−1 of meso-2,3-BD in 12 h. In comparison, only 17.8 g L−1 of (3S)-AC was produced by recombinant E. coli BL21(DE3) (pETDuet-ydjL) under identical conditions. Low conversion rate was observed by the wild-type E. coli BL21(DE3) strain, and the final concentration of (3S)-AC was only 0.6 g L−1. When (2R,3R)-2,3-BD was used as the substrate, (3R)-AC was produced. The highest concentration of (3R)-AC (41.8 g L−1) was obtained when the concentration of (2R,3R)-2,3-BD was 43 g L−1. Since (3S)-AC and (3R)-AC standards could be separated by GC, the ee of the products was calculated by the amount of each isomer. The two isomers of AC were produced in 96.0% ee. The results from GC analyses of substrates and products of the catalytic reaction are shown in Fig. 5A, B.
The concentration of (3S)-AC (□) and meso-2,3-BD (▪) in E. coli BL21(DE3) (pETDuet-ydjLnox) ; concentrations of (3S)-AC (○) and meso-2,3-BD (•) in E. coli BL21(DE3) (pETDuet-ydjL); and concentrations of (3S)-AC (▵) and meso-2,3-BD (▴) in E. coli BL21(DE3).
A. Conversion of meso-2,3-BD to (3S)-AC: A1-before the reaction; A2-after the reaction; B. Conversion of (2R,3R)-2,3-BD to (3R)-AC: B1-before the reaction; B2-after the reaction; C. The starting material and products of kinetic resolution from a mixture of 2,3-BD: C1-before the reaction; C2-after the reaction.
The production of chiral AC by biocatalysis has been reported earlier –. Yamada-Onodera et al. reported that about 9.68 g L−1 of both (3R)-AC from (2R,3R)-2,3-BD and (3S)-AC from meso-2,3-BD were obtained after 24 h of incubation with recombinant E. coli expressing only glycerol dehydrogenase (GDH) . In this study, a recombinant strain that coexpressed (2R,3R)-2,3-BDH and NOX was constructed, and the yield of both (3S)-AC and (3R)-AC was found to be much higher than that in previous reports. The results also showed that the recombinant strain that coexpressed (2R,3R)-2,3-BDH and NOX was significantly more efficient than the recombinant strain that only expressed (2R,3R)-2,3-BDH in terms of AC production. As shown in Fig. 4, the yield of (3S)-AC from the two-enzyme system was 42.8% higher than that from the one-enzyme system (similar result was found for (3R)-AC production, data not shown).
(2S,3S)-2,3-BD Production by Kinetic Resolution
2,3-BD, the hydrogenation product of AC, is not only used as a fuel, but also as a valuable chemical feedstock –. (2S,3S)-2,3-BD can also be used as an antifreeze agent due to its low freezing point (−60°C) –. However, to date, no microorganism capable of producing enantiopure (2S,3S)-2,3-BD has been identified. In this study, (2S,3S)-2,3-BD was produced by kinetic resolution from a mixture of 2,3-BD using the whole-cell biocatalyst of E. coli BL21(DE3) (pETDuet-ydjLnox). When a mixture of 20.0 g L−1 2,3-BD was incubated with E. coli BL21(DE3) (pETDuet-ydjLnox) at pH 8.0 and 37°C, 2.4 g L−1 of (2S,3S)-2,3-BD and 17.2 g L−1 of AC were produced in 10 h, and the ee of the (2S,3S)-2,3-BD finally obtained was higher than 99.0%. The results from GC analyses of substrates and products of the catalytic reaction are shown in Fig. 5C.
Although the yield of (2S,3S)-2,3-BD was not very high due to the low content of (2S,3S)-2,3-BD in the mixture of 2,3-BD (only 12.4%), the biocatalytic efficiency of the (2R,3R)-2,3-BDH and NOX coexpressing recombinant strain was much higher than that of recombinant E. coli expressing GDH only (1.4 g L−1) . This shows that the incorporation of a cofactor regeneration system in the E. coli whole-cell biocatalyst is a powerful strategy for enhancing the catalytic efficiency of oxidoreductases.
Many dehydrogenases that are useful in industrial production are cofactor-dependent. By using a suitable enantioselective dehydrogenase, important enantiomerically pure compounds can be prepared by kinetic resolution. For example, NAD+ dependent (S)-ADH can be used for the production of (R)-phenylethanol from a racemate with 100% ee and 100% yield. Regeneration of the cofactor is important in large-scale applications of coenzyme-dependent reactions . NAD(P)H regeneration has been widely studied, whereas NAD(P)+ regeneration, which is required for reactions involving the oxidized forms of the pyridine nucleotide cofactors, is less well developed . An NAD-dependent alcohol dehydrogenase from L. brevis coupled with the NOX from Lactobacillus sanfranciscensis was successfully used to produce enantiomerically pure alcohol from a racemic mixture . The two enzymes were first purified, and then coupled in a reaction in which NOX was used to regenerate the oxidized cofactor. Although this method did not generate any byproducts, the complex purification processes and the oxygen sensitivity of NOX precluded its applications on a preparative scale .
In comparison with isolated enzymes, utilization of whole-cell biocatalysts circumvents laborious protein purification steps, which simplifies the reactions in many cases. NAD(P)+ regeneration in whole-cell biocatalysts would help in extending the applications of NAD(P)-dependent oxidoreductases. In this study, we constructed a novel whole-cell biocatalyst from recombinant E. coli in which (2R,3R)-2,3-BDH and NOX were coexpressed to catalyze the production of (3R)-AC, (3S)-AC, and (2S,3S)-2,3-BD with high ee. The present study clearly demonstrates the importance of providing sufficient amounts of the oxidized form of the pyridine nucleotide cofactors to NAD-dependent dehydrogenases. The value of the NAD+ regeneration technique presented in this paper could extend beyond chiral AC and (2S,3S)-2,3-BD production to other chiral chemicals. Coupling NOX from L. brevis in the biocatalytic system provided a suitable method for NAD+ regeneration, and this should open up the possibilities for constructing other whole-cell biocatalysts with different NAD-dependent dehydrogenases.
Materials and Methods
Meso-2,3-BD (98.0%) and (2R,3R)-2,3-BD (98.0%) were purchased from ACROS. The mixture of 2,3-BD (75.0% meso-2,3-BD, 12.6% (2R,3R)-2,3-BD, and 12.4% (2S,3S)-2,3-BD) was obtained from Sinopharm (Beijing, China). Ampicillin and NADH were from Amresco. Isopropyl-β-D-1-thiogalactopyranoside (IPTG) and phenylmethanesulfonyl fluoride (PMSF) were from Merck. All other chemicals were commercially available reagents of analytical grade. PCR primers were prepared by Sangon (Shanghai, China). Pfu DNA polymerase was obtained from Promega (USA). T4 DNA ligase and restriction endonucleases were obtained from Fermentas (Lithuania).
Constructions of E. coli BL21(DE3) (pETDuet-ydjL), E. coli BL21(DE3) (pETDuet-nox) and E. coli BL21(DE3) (pETDuet-ydjLnox)
The bacterial strains and plasmids used in this study are listed in Table 2. B. subtilis 168 genomic DNA was extracted with the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA). The ydjL gene was amplified by PCR using forward primer py1 with an NcoΙ restriction site insertion and reverse primer py2 with a SalΙ restriction site insertion. The PCR product was firstly ligated to the pEasy-Blunt vector, and the resulting plasmid was designated pEasy-Blunt-ydjL. The pEasy-Blunt-ydjL was then sequenced (Sangon, Shanghai, China) to verify that no mutations were introduced by PCR. Next, to construct the recombinant plasmid pETDuet-ydjL under the control of the T7 promoter, pEasy-Blunt-ydjL was digested with NcoΙ and SalΙ, and the gel-purified ydjL fragment was ligated to the pETDuet-1 vector that had been digested with the same restriction enzymes. Using the same process that described above, the nox gene fragment was obtained from the genome of L. brevis using primers pn1 (with the BglII restriction site) and pn2 (with the XhoΙ restriction site). To construct a coexpression system carrying ydjL and nox, pEasy-Blunt-nox was digested with BglII and XhoΙ, and the gel-purified nox fragment was ligated to pETDuet-ydjL digested with the same restriction enzymes. E. coli DH5α was used for general cloning, and E. coli BL21(DE3) was used for protein expression. Luria-Bertani (LB) medium was used for both E. coli and B. subtilis culture. DeMan-Rogosa Sharpe (MRS) medium was used for L. brevis culture.
Recombinant E. coli cells were grown at 37°C on a rotary shaker (180 rpm) in LB medium containing ampicillin (100 µg mL−1) to an OD620nm value of 0.6. Expression of the recombinant gene was induced by adding 1 mM IPTG at 16°C to avoid the formation of inactive inclusion bodies. After induction, the cells were harvested by centrifugation at 6,000×g for 5 min at 4°C and then washed twice with 1/15 M phosphate buffer (PB) (pH 7.4). The cell pellet was resuspended in 1/15 M PB (pH 7.4), and maintained at 4°C for further studies.
(2R,3R)-2,3-BDH and NOX Activity Assays
The harvested cells were resuspended in 20% glycerol, 0.1 mM PMSF, and 1 mM DTT in 1/15 M PB (pH 7.4) and disrupted for 20 min (5 s + 5 s) using a sonicator. The disrupted cells were centrifuged for 10 min at 10,000×g at 4°C, and the supernatant was used as the crude cell extract. The (2R,3R)-2,3-BDH and NOX activities were assayed by measuring the decrease in NADH (0.2 mM) at 340 nm using a UV/visible spectrophotometer (Ultrospec 2100 pro, Amersham Biosciences, USA) , . The protein concentration was determined by the Bradford method using bovine serum albumin as the standard .
Assay of Whole-Cell Biocatalytic Activity
The whole-cell biocatalytic activity was assayed by measuring the increase of AC in the reaction solution. The reaction solution consisting of 10.0 g L−1 2,3-BD and the whole-cell biocatalyst (the final concentration was 1.5 g DCW L−1) in 200 mM PB (pH 8.0) was incubated at 37°C on a rotary shaker for 20 min. The mixture was centrifuged at 6,000×g for 5 min to stop the reaction, and the AC concentration in the supernatant was measured. One unit of whole-cell biocatalytic activity was defined as the amount of cells that catalyzed the formation of 1.0 µmol of AC per minute at 37°C.
Reaction with 20 mL of mixture in a 250-mL Erlenmeyer flask at 37°C and 200 rpm were performed at pH 8.0. The cell concentration in the reaction was 5.0 g DCW L−1. To produce chiral AC, the harvested biocatalyst was resuspended in 200 mM PB (pH 8.0) containing 43 g L−1 meso-2,3-BD or (2R,3R)-2,3-BD. For the kinetic resolution of (2S,3S)-2,3-BD from the 2,3-BD mixture, the harvested biocatalyst was resuspended in 200 mM PB (pH 8.0) containing 20 g L−1 of 2,3-BD.
Samples (0.15 mL) were taken periodically and centrifuged at 15,000×g. The concentrations of 2,3-BD and AC in the supernatant were analyzed by GC. Prior to GC analysis, the supernatant was extracted with an equal volume of ethyl acetate after the addition of isoamyl alcohol as the internal standard. The GC (Agilent GC6820) system consisted of a flame ionization detector and a fused silica capillary column (Supelco Beta DEX™ 120, inside diameter, 0.25 mm; length, 30 m). The operating conditions were as follows. Nitrogen was used as the carrier gas. The injector temperature and detector temperature were both 280°C. The column oven was maintained at 40°C for 3 min and then programmed to increase to 80°C at a rate of 1.5°C min−1. The temperature was then raised to 86°C at a rate of 0.5°C min−1 and finally to 200°C at a rate of 30°C min−1. The injection volume was 3 µL. In this study, the ee values of (3S)-AC and (3R)-AC were calculated as and , respectively, where [R] and [S] represent the concentrations of (3R)-AC and (3S)-AC, respectively.
Conceived and designed the experiments: ZX CL CG CM PX. Performed the experiments: CL CG ZL PL. Analyzed the data: ZX CL CG JQ CM LL PX. Contributed reagents/materials/analysis tools: JQ CM PX. Wrote the paper: CL CG PX.
- 1. Agranat I, Caner H, Caldwell J (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1: 753–768.I. AgranatH. CanerJ. Caldwell2002Putting chirality to work: the strategy of chiral switches.Nat Rev Drug Discov1753768
- 2. Schoemaker HE, Mink D, Wubbolts MG (2003) Dispelling the myths—biocatalysis in industrial synthesis. Science 299: 1694–1697.HE SchoemakerD. MinkMG Wubbolts2003Dispelling the myths—biocatalysis in industrial synthesis.Science29916941697
- 3. van der Donk WA, Zhao H (2003) Recent developments in pyridine nucleotide regeneration. Curr Opin Biotechnol 14: 421–426.WA van der DonkH. Zhao2003Recent developments in pyridine nucleotide regeneration.Curr Opin Biotechnol14421426
- 4. Kim MJ, Whitesides GM (1988) L-Lactate dehydrogenase: substrate specificity and use as a catalyst in the synthesis of homochiral 2-hydroxy acids. J Am Chem Soc 110: 2959–2964.MJ KimGM Whitesides1988L-Lactate dehydrogenase: substrate specificity and use as a catalyst in the synthesis of homochiral 2-hydroxy acids.J Am Chem Soc11029592964
- 5. Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, et al. (2001) Industrial biocatalysis today and tomorrow. Nature 409: 258–268.A. SchmidJS DordickB. HauerA. KienerM. Wubbolts2001Industrial biocatalysis today and tomorrow.Nature409258268
- 6. Chenault HK, Whitesides GM (1987) Regeneration of nicotinamide cofactors for use in organic synthesis. Appl Biochem Biotechnol 14: 147–197.HK ChenaultGM Whitesides1987Regeneration of nicotinamide cofactors for use in organic synthesis.Appl Biochem Biotechnol14147197
- 7. Wichmann R, Vasic-Racki D (2005) Cofactor regeneration at the lab scale. Adv Biochem Eng Biotechnol 92: 225–260.R. WichmannD. Vasic-Racki2005Cofactor regeneration at the lab scale.Adv Biochem Eng Biotechnol92225260
- 8. Endo T, Koizumi S (2001) Microbial conversion with cofactor regeneration using engineered bacteria. Adv Synth Catal 343: 521–526.T. EndoS. Koizumi2001Microbial conversion with cofactor regeneration using engineered bacteria.Adv Synth Catal343521526
- 9. Galkin A, Kulakova L, Yoshimura T, Soda K, Esaki N (1997) Synthesis of optically active amino acids from alpha-keto acids with Escherichia coli cells expressing heterologous genes. Appl Environ Microbiol 63: 4651–4656.A. GalkinL. KulakovaT. YoshimuraK. SodaN. Esaki1997Synthesis of optically active amino acids from alpha-keto acids with Escherichia coli cells expressing heterologous genes.Appl Environ Microbiol6346514656
- 10. Saito S, Inoue H, Ohno K (1992) Alpha-hydroxyketone derivatives, liquid crystal compositions containing said derivatives, and liquid crystal devices using said compositions. US Patent 5,164,112. S. SaitoH. InoueK. Ohno1992Alpha-hydroxyketone derivatives, liquid crystal compositions containing said derivatives, and liquid crystal devices using said compositions.US Patent 5,164,112
- 11. Xiao ZJ, Liu PH, Qin JY, Xu P (2007) Statistical optimization of medium components for enhanced acetoin production from molasses and soybean meal hydrolysate. Appl Microbiol Biotechnol 74: 61–68.ZJ XiaoPH LiuJY QinP. Xu2007Statistical optimization of medium components for enhanced acetoin production from molasses and soybean meal hydrolysate.Appl Microbiol Biotechnol746168
- 12. González E, Fernández MR, Larroy C, Solà L, Pericàs MA, et al. (2000) Characterization of a (2R,3R)-2,3-butanediol dehydrogenase as the Saccharomyces cerevisiae YAL060W gene product. Disruption and induction of the gene. J Biol Chem 275: 35876–35885.E. GonzálezMR FernándezC. LarroyL. SolàMA Pericàs2000Characterization of a (2R,3R)-2,3-butanediol dehydrogenase as the Saccharomyces cerevisiae YAL060W gene product. Disruption and induction of the gene.J Biol Chem2753587635885
- 13. Höhn-Bentz H, Radler F (1978) Bacterial 2,3-butanediol dehydrogenases. Arch Microbiol 116: 197–203.H. Höhn-BentzF. Radler1978Bacterial 2,3-butanediol dehydrogenases.Arch Microbiol116197203
- 14. Hosaka T, Ui S, Ohtsuki T, Mimura A, Ohkuma M, et al. (2001) Characterization of the NADH-linked acetylacetoin reductase/2,3-butanediol dehydrogenase gene from Bacillus cereus YUF-4. J Biosci Bioeng 91: 539–544.T. HosakaS. UiT. OhtsukiA. MimuraM. Ohkuma2001Characterization of the NADH-linked acetylacetoin reductase/2,3-butanediol dehydrogenase gene from Bacillus cereus YUF-4.J Biosci Bioeng91539544
- 15. Riebel BR, Gibbs PR, Wellborn WB, Bommarius AS (2003) Cofactor regeneration of both NAD+ from NADH and NADP+ from NADPH: NADH oxidase from Lactobacillus sanfranciscensis. Adv Synth Catal 345: 707–712.BR RiebelPR GibbsWB WellbornAS Bommarius2003Cofactor regeneration of both NAD+ from NADH and NADP+ from NADPH: NADH oxidase from Lactobacillus sanfranciscensis.Adv Synth Catal345707712
- 16. Findrik Z, Vrsalović Presecki A, Vasić-Racki D (2007) Mathematical modelling of NADH oxidation catalyzed by new NADH oxidase from Lactobacillus brevis in continuously operated enzyme membrane reactor. J Biosci Bioeng 104: 275–280.Z. FindrikA. Vrsalović PreseckiD. Vasić-Racki2007Mathematical modelling of NADH oxidation catalyzed by new NADH oxidase from Lactobacillus brevis in continuously operated enzyme membrane reactor.J Biosci Bioeng104275280
- 17. Geueke B, Riebel B, Hummel W (2003) NADH oxidase from Lactobacillus brevis: a new catalyst for the regeneration of NAD. Enzyme Microb Technol 32: 205–211.B. GeuekeB. RiebelW. Hummel2003NADH oxidase from Lactobacillus brevis: a new catalyst for the regeneration of NAD.Enzyme Microb Technol32205211
- 18. Hummel W, Riebel B (2003) Isolation and biochemical characterization of a new NADH oxidase from Lactobacillus brevis. Biotechnol Lett 25: 51–54.W. HummelB. Riebel2003Isolation and biochemical characterization of a new NADH oxidase from Lactobacillus brevis.Biotechnol Lett255154
- 19. Ishige T, Honda K, Shimizu S (2005) Whole organism biocatalysis. Curr Opin Chem Biol 9: 174–180.T. IshigeK. HondaS. Shimizu2005Whole organism biocatalysis.Curr Opin Chem Biol9174180
- 20. Yamada-Onodera K, Yamamoto H, Kawahara N, Tani Y (2002) Expression of the gene of glycerol dehydrogenase from Hansenula polymorpha D1-1 in Escherichia coli for the production of chiral compounds. Acta Biotechnol 22: 355–362.K. Yamada-OnoderaH. YamamotoN. KawaharaY. Tani2002Expression of the gene of glycerol dehydrogenase from Hansenula polymorpha D1-1 in Escherichia coli for the production of chiral compounds.Acta Biotechnol22355362
- 21. Ui S, Mimura A, Okuma M, Kudo T (1998) The production of D-acetoin by a transgenic Escherichia coli. Lett Appl Microbiol 26: 275–278.S. UiA. MimuraM. OkumaT. Kudo1998The production of D-acetoin by a transgenic Escherichia coli.Lett Appl Microbiol26275278
- 22. Garg SK, Jain A (1995) Fermentative production of 2,3-butanediol: a review. Bioresour Technol 51: 103–109.SK GargA. Jain1995Fermentative production of 2,3-butanediol: a review.Bioresour Technol51103109
- 23. Syu MJ (2001) Biological production of 2,3-butanediol. Appl Microbiol Biotechnol 55: 10–18.MJ Syu2001Biological production of 2,3-butanediol.Appl Microbiol Biotechnol551018
- 24. Hummel W (1999) Large-scale applications of NAD(P)-dependent oxidoreductases: recent developments. Trends Biotechnol 17: 487–492.W. Hummel1999Large-scale applications of NAD(P)-dependent oxidoreductases: recent developments.Trends Biotechnol17487492
- 25. Nicholson WL (2008) The Bacillus subtilis ydjL (bdhA) gene encodes acetoin reductase/2,3-butanediol dehydrogenase. Appl Environ Microbiol 74: 6832–6838.WL Nicholson2008The Bacillus subtilis ydjL (bdhA) gene encodes acetoin reductase/2,3-butanediol dehydrogenase.Appl Environ Microbiol7468326838
- 26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.MM Bradford1976A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem72248254